2020
DOI: 10.3390/ijms21207677
|View full text |Cite
|
Sign up to set email alerts
|

Binding Mode Exploration of B1 Receptor Antagonists’ by the Use of Molecular Dynamics and Docking Simulation—How Different Target Engagement Can Determine Different Biological Effects

Abstract: The kinin B1 receptor plays a critical role in the chronic phase of pain and inflammation. The development of B1 antagonists peaked in recent years but almost all promising molecules failed in clinical trials. Little is known about these molecules’ mechanisms of action and additional information will be necessary to exploit the potential of the B1 receptor. With the aim of contributing to the available knowledge of the pharmacology of B1 receptors, we designed and characterized a novel class of allosteric non-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 53 publications
0
3
0
Order By: Relevance
“…2A, B). Measurement of bipedal balance using weight-bearing asymmetry [39] and von Frey test using the dynamic plantar tactile device [40] were performed on all surviving animals on Day-7, 0, 7, 21, 35, and 49. All animals were euthanized on Day 54.…”
Section: Animalsmentioning
confidence: 99%
“…2A, B). Measurement of bipedal balance using weight-bearing asymmetry [39] and von Frey test using the dynamic plantar tactile device [40] were performed on all surviving animals on Day-7, 0, 7, 21, 35, and 49. All animals were euthanized on Day 54.…”
Section: Animalsmentioning
confidence: 99%
“…Measurement of bipedal balance using weight-bearing asymmetry [39] and von Frey test using the dynamic plantar tactile device [40] were performed on all surviving animals before modeling, one week after modelling, and one week after each administration.…”
Section: Preparation Of Ceffementioning
confidence: 99%
“…As illustrated in Figure 1, bradykinin possesses vasorelaxant and natriuretic activity, where it inhibits sodium reabsorption via NO and prostacyclin (PGI2)-coupled BKB2R and provokes pain (25,47,49,62,65). In contrast, [des-Arg9]-BK induces pain probably due to its proinflammatory, coagulation and proliferative actions along enhanced vascular permeability and edema formation, mediated by BKB1R (24,29,37,50,62). However, [des-Arg9]-BK also has low affinity to the BKB2R in some tissues, likely explaining how selective BKB2R blocker (icatibant) may exert antiinflammatory pulmonary effects in patients with ARDS (57).…”
Section: Introductionmentioning
confidence: 99%